LOGC

ContextLogic (LOGC)

ContextLogic Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LOGC

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/11	06 : 40	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:LOGC	ContextLogic Inc
2022/11/30	06 : 07	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:LOGC	ContextLogic Inc
2022/11/21	20 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06 : 05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06 : 05	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06 : 04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06 : 04	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LOGC	ContextLogic Inc
2022/11/17	06 : 04	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:LOGC	ContextLogic Inc
2022/11/16	23 : 56	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:LOGC	ContextLogic Inc
2022/11/16	22 : 30	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:LOGC	ContextLogic Inc
2022/11/16	22 : 21	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:LOGC	ContextLogic Inc
2022/11/14	22 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:LOGC	ContextLogic Inc
2022/11/14	22 : 11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/11/14	22 : 00	PR Newswire (US)	LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates	NASDAQ:LOGC	ContextLogic Inc
2022/10/20	21 : 55	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:LOGC	ContextLogic Inc
2022/10/19	05 : 14	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:LOGC	ContextLogic Inc
2022/10/19	05 : 04	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:LOGC	ContextLogic Inc
2022/10/14	05 : 02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:LOGC	ContextLogic Inc
2022/10/08	05 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/10/04	05 : 47	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:LOGC	ContextLogic Inc
2022/10/04	00 : 20	Dow Jones News	LogicBio Therapeutics Shares Soar on Takeover by AstraZeneca	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	23 : 50	TipRanks	Analysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	21 : 19	TipRanks	AstraZeneca to Buy LogicBio Therapeutics for $2.07 Per Share	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20 : 57	Dow Jones News	AstraZeneca to Buy LogicBio Therapeutics for $68 Million	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20 : 15	Business Wire	Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/10/03	20 : 00	PR Newswire (US)	Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine	NASDAQ:LOGC	ContextLogic Inc
2022/09/24	06 : 28	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc
2022/09/21	21 : 30	PR Newswire (US)	LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONE	NASDAQ:LOGC	ContextLogic Inc
2022/09/21	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LOGC	ContextLogic Inc